Funder: Vertex Pharmaceuticals
Due Dates: Rolling (most programs) | 2026 (next cycle for Circle of Care, RIA, VIA awards)
Funding Amounts: No set cap for most grants; CF Research Innovation Awards: up to $750,000 over 3 years; VIA: up to $750,000/project; Mentored RIA: up to $125,000 over 2 years
Summary: Supports independent research, educational initiatives, and sponsorships advancing knowledge and care in cystic fibrosis and other Vertex-priority diseases.
Key Information: Rolling submissions for most areas; specific RFP cycles for beta thalassemia and sickle cell disease; overhead generally capped at 35%.